|
End-of-day quote
Korea S.E.
2026-11-05
|
5-day change | 1st Jan Change | ||
| 4,335.00 KRW | -5.66% |
|
-0.23% | -15.00% |
| 23-05-11 | Optipharm.CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 22-09-19 | Optipharm.CO.,LTD(KOSDAQ:A153710) dropped from S&P Global BMI Index | CI |
| Market Cap | 63.59B 47.02M 41.9M 38.32M 34.9M 65.79M 4.44B 67.56M 460M 184M 2.35B 176M 173M 7.43B | P/E 2024 |
-28.9x | P/E 2025 | -29.9x |
|---|---|---|---|---|---|
| Enterprise Value | 64.27B 47.52M 42.34M 38.73M 35.27M 66.48M 4.49B 68.28M 465M 186M 2.38B 178M 175M 7.5B | EV / Sales 2024 |
3.31x | EV / Sales 2025 | 3.38x |
| Free-Float |
58.92% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -5.66% | ||
| 1 week | -0.23% | ||
| Current month | +2.12% | ||
| 1 month | -3.67% | ||
| 3 months | -8.54% | ||
| 6 months | -15.50% | ||
| Current year | -15.00% |
| 1 week | 4,115 |  | 4,595 |
| 1 month | 4,115 | | 4,670 |
| Current year | 4,075 | | 6,030 |
| 1 year | 4,075 | | 6,250 |
| 3 years | 4,075 | | 7,870 |
| 5 years | 4,075 | | 14,800 |
| 10 years | 4,075 | | 31,150 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hyun-Il Kim
CEO | Chief Executive Officer | 54 | 2019-03-31 |
Beom-Gu Han
PRN | Corporate Officer/Principal | 57 | 2022-03-23 |
Ki-Myung Choi
PRN | Corporate Officer/Principal | 54 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hyun-Il Kim
BRD | Director/Board Member | 54 | 2019-03-25 |
Ki-Myung Choi
BRD | Director/Board Member | 54 | - |
Hyeon-Wuk Choi
BRD | Director/Board Member | 51 | 2021-03-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0068% | ||
| 1/27/26 | Buy | Chief Executive Officer | 1,000 | 0.0068% | ||
| 1/27/26 | Buy | Chief Executive Officer | 5,000 | 0.0341% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.66% | -0.23% | -12.34% | -38.68% | 47.02M | |
| -3.76% | -0.65% | +47.41% | +140.35% | 1,216B | |
| -1.45% | -1.05% | +46.41% | +79.94% | 656B | |
| -2.24% | -0.88% | +32.97% | +103.82% | 509B | |
| -1.88% | -4.64% | +45.06% | +62.22% | 384B | |
| -2.27% | +0.42% | +74.12% | +42.14% | 362B | |
| -2.31% | -2.12% | +28.47% | +55.44% | 311B | |
| -3.01% | -2.26% | +6.31% | +32.78% | 293B | |
| -3.80% | -0.10% | +43.90% | +70.56% | 249B | |
| -3.96% | +1.18% | +36.70% | +105.38% | 208B | |
| Average | -3.03% | +0.75% | +34.90% | +65.39% | 418.78B | |
| Weighted average by Cap. | -2.76% | +0.03% | +42.57% | +91.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 19.64B 14.52M 12.94M 11.83M 10.78M 20.31M 1.37B 20.86M 142M 56.85M 727M 54.49M 53.32M 2.29B | 22.34B 16.52M 14.72M 13.47M 12.26M 23.12M 1.56B 23.74M 162M 64.69M 827M 62.01M 60.68M 2.61B |
| Net income | -2.36B -1.74M -1.55M -1.42M -1.29M -2.44M -165M -2.5M -17.06M -6.82M -87.2M -6.54M -6.4M -275M | -2.5B -1.85M -1.65M -1.51M -1.37M -2.59M -175M -2.66M -18.09M -7.24M -92.48M -6.94M -6.79M -292M |
| Net Debt | -3.22B -2.38M -2.12M -1.94M -1.77M -3.33M -225M -3.42M -23.33M -9.33M -119M -8.94M -8.75M -376M | 672M 497K 443K 405K 369K 695K 46.95M 714K 4.86M 1.95M 24.86M 1.86M 1.82M 78.46M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-05 | ₩4,335.00 | -5.66% | 14,409 |
| 26-11-04 | ₩4,595.00 | +9.80% | 6,987 |
| 26-11-03 | ₩4,185.00 | -0.71% | 4,729 |
| 26-11-02 | ₩4,215.00 | -0.71% | 5,903 |
| 26-10-30 | ₩4,245.00 | -2.30% | 8,115 |
- Stock Market
- Stocks
- A153710 Stock
Select your edition
All financial news and data tailored to specific country editions
